All News

2018

April

Media Release / Apr 20, 2018

New Novartis analyses at AAN show siponimod's efficacy on disability and cognition in secondary progressive MS patients

Read More
Media Release / Apr 19, 2018

Novartis appoints John Tsai Head of Global Drug Development and Chief Medical Officer

Read More
Media Release / Apr 19, 2018

Novartis delivered a strong first quarter and acted to become a more focused medicines company

Read More
Media Release / Apr 18, 2018

Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders

Read More
Media Release / Apr 17, 2018

Novartis presents first-of-its-kind evidence at AAN reinforcing robust and consistent efficacy of AimovigTM* (erenumab) for migraine patients with multiple treatment failures

Read More
Media Release / Apr 17, 2018

Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials

Read More
Media Release / Apr 17, 2018

Novartis tender offer for AveXis commences

Read More
Media Release / Apr 16, 2018

Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes

Read More
Media Release / Apr 09, 2018

Novartis enters agreement to acquire AveXis Inc. for USD 8.7 bn to transform care in SMA and expand position as a gene therapy and Neuroscience leader

Read More
Media Release / Apr 07, 2018

Sandoz outlines plans for next Healthcare Access Challenge (HACk), to support local digital innovation

Read More

Pages

Related Links

Annual Report 2017

Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.

Learn More